- Release Date: 12/07/22 09:35
- Summary: Neuren commences Phase 2 trial of NNZ-2591 in Angelman
- Price Sensitive: Yes
- Download Document 154.47KB
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman
Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.82 |
Change
0.490(3.00%) |
Mkt cap ! $2.139B |
Open | High | Low | Value | Volume |
$16.49 | $16.89 | $16.44 | $6.378M | 382.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 79 | $16.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.82 | 152 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 63 | 16.810 |
8 | 1443 | 16.800 |
12 | 1339 | 16.790 |
4 | 553 | 16.780 |
5 | 828 | 16.770 |
Price($) | Vol. | No. |
---|---|---|
16.820 | 144 | 8 |
16.830 | 338 | 5 |
16.840 | 1138 | 9 |
16.850 | 1051 | 7 |
16.860 | 720 | 5 |
Last trade - 14.32pm 12/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online